Shenzhen YHLO Biotech CoSHSE:688575 -3.03%64 Quick Ratio is 1.53 as of Mar. 2026, which is 9% above its 10-year median of 1.41. GuruFocus rates SHSE:688575 with a GF Score™ of 64/100 and a GF Value™ of ¥14.51 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Shenzhen YHLO Biotech Co ranks worse than 59.25% on this metric.
Shenzhen YHLO Biotech Co has a quick ratio of 1.53. It generally indicates good short-term financial strength.
The historical rank and industry rank for Shenzhen YHLO Biotech Co's Quick Ratio or its related term are showing as below:
SHSE:688575'
s Quick Ratio Range Over the Past 10 Years
Min: 0.69 Med: 1.41 Max: 1.86
Current: 1.53
During the past 9 years, Shenzhen YHLO Biotech Co's highest Quick Ratio was 1.86. The lowest was 0.69. And the median was 1.41.
SHSE:688575's Quick Ratio is ranked worse than 59.25% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.885
vs SHSE:688575: 1.53
Shenzhen YHLO Biotech Co (SHSE:688575) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Shenzhen YHLO Biotech Co Quick Ratio Related Terms
Shenzhen YHLO Biotech Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688575 vs ABT, SYK, MDT: Quick Ratio Comparison
For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen YHLO Biotech Co Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Shenzhen YHLO Biotech Co's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Shenzhen YHLO Biotech Co's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen YHLO Biotech Co (SHSE:688575) has a Quick Ratio of 1.53 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shenzhen YHLO Biotech Co and its competitors. This is near median its historical median of 1.41. Over the past decade, Shenzhen YHLO Biotech Co's Quick Ratio has ranged from 0.69 to 1.86. According to the industry distribution chart, Shenzhen YHLO Biotech Co ranks #506 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 59.3%.
Is Shenzhen YHLO Biotech Co's Quick Ratio too high?
Shenzhen YHLO Biotech Co's current Quick Ratio of 1.53 is near median its 10-year median of 1.41. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 1.86. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Shenzhen YHLO Biotech Co's value of 1.53 is 18.8% below this industry median. Based on the distribution chart, Shenzhen YHLO Biotech Co ranks #506 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shenzhen YHLO Biotech Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen YHLO Biotech Co's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen YHLO Biotech Co ranks #506 out of 854 companies for Quick Ratio. This places Shenzhen YHLO Biotech Co in the lower half of its industry. The industry median Quick Ratio is 1.89. Shenzhen YHLO Biotech Co's value of 1.53 is 18.8% below this benchmark. Historically, Shenzhen YHLO Biotech Co's own Quick Ratio has ranged from 0.69 to 1.86 over the past decade. While the company's 10-year median is 1.41 vs. the industry median of 1.89, Shenzhen YHLO Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen YHLO Biotech Co's current Quick Ratio of 1.53 is 18.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shenzhen YHLO Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen YHLO Biotech Co's current Quick Ratio is 1.53, which is near median its own 10-year median of 1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen YHLO Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co (SHSE:688575) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥14.51, compared to a current price of ¥8.97 — trading 38.2% below its estimated fair value. The current Quick Ratio is 1.53, which is near median its 10-year median of 1.41 and 18.8% below the Medical Devices & Instruments industry median of 1.89. Shenzhen YHLO Biotech Co's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Shenzhen YHLO Biotech Co (SHSE:688575), the current Quick Ratio is 1.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen YHLO Biotech Co (SHSE:688575) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co stock appears to be undervalued.
The current stock price of ¥8.97 is trading 38.2% below its estimated GF Value™ of ¥14.51.
GuruFocus considers Shenzhen YHLO Biotech Co to be Significantly Undervalued.
Key valuation signals for SHSE:688575:
Quick Ratio: 1.53 (near median its 10-year median of 1.41)
GF Value™: ¥14.51 vs. price of ¥8.97 (38.2% below fair value)
Industry Position: 18.8% below the Medical Devices & Instruments median (#506 of 854)
No single metric tells the full story. See the SHSE:688575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
64GF Score
Get the complete analysis for SHSE:688575
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688575 has been successfully added to your 
